- Home
- HAE vs SUNC Comparison
HAE vs SUNC Comparison
Compare HAE & SUNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HAE | SUNC |
|---|---|---|
| Founded | 1971 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8B | 4.0B |
| IPO Year | 1996 | 2025 |
Fundamental Metrics
Financial Performance| Metric | HAE | SUNC |
|---|---|---|
| Price | $102.92 | $79.55 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 2 |
| Target Price | ★ $84.13 | $61.00 |
| AVG Volume (30 Days) | ★ 663.1K | 377.7K |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 5.74% |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.72 | ★ 2.89 |
| Revenue | $910,373,000.00 | ★ $25,201,000,000.00 |
| Revenue This Year | N/A | $65.29 |
| Revenue Next Year | $5.23 | $0.84 |
| P/E Ratio | $142.94 | ★ $27.53 |
| Revenue Growth | N/A | ★ 11.05 |
| 52 Week Low | $47.32 | $47.00 |
| 52 Week High | $109.57 | $79.83 |
Technical Indicators
Market Signals| Indicator | HAE | SUNC |
|---|---|---|
| Relative Strength Index (RSI) | 62.29 | 55.92 |
| Support Level | $79.52 | $74.68 |
| Resistance Level | $109.57 | $78.21 |
| Average True Range (ATR) | 2.59 | 1.72 |
| MACD | -0.93 | -0.04 |
| Stochastic Oscillator | 62.50 | 59.71 |
Price Performance
Historical ComparisonAbout HAE Haemonetics Corporation
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The Plasma segment includes end-to-end collection technologies, automated plasmapheresis systems (such as the NexSys PCS device), and donor management software designed for commercial plasma collectors. Hospital segment includes Blood Management Technologies (hemostasis analyzers, cell salvage systems) and Interventional Technologies. And the Blood Center provides solutions and devices enabling blood centers to harvest essential components like platelets and red blood cells.
About SUNC SunocoCorp LLC
SunocoCorp LLC is a publicly traded limited liability company that owns a direct limited partner interest in Sunoco LP. It engages in the management and distribution of fuel products. It operates through the following segments: Fuel Distribution, Pipeline Systems, and Terminals and Refinery.